Dastrup; David

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dastrup; David.The latest application filed is for "anti-sway device".

Company Profile

0.11.13

Dastrup; David - Escondido CA US
Dastrup; David - Orem UT
Dastrup; David - Weslake OH
Dastrup; David - Westlake OH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anti-sway Device App 20160206944 - Dastrup; David	2016-07-21
Golf Tee App 20160166898 - Dastrup; David	2016-06-16
Golf tee Grant D741,424 - Dastrup October 20, 2	2015-10-20
Golf Club Towel Assembly App 20150190689 - Dastrup; David	2015-07-09
Golf club towel assembly Grant 9,010,705 - Dastrup April 21, 2	2015-04-21
Golf green slope reading aid Grant 8,632,427 - Dastrup January 21, 2	2014-01-21
Golf Club Towel Assembly App 20120256067 - Dastrup; David	2012-10-11
Golf Green Slope Reading Aid App 20120065001 - Dastrup; David	2012-03-15
Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disorders Grant 8,129,424 - Bennani , et al. March 6, 2	2012-03-06
Pyrazoles for the treatment of obesity and other CNS disorders Grant 7,981,896 - Bennani , et al. July 19, 2	2011-07-19
Pyrazoles For The Treatment Of Obesity And Other Cns Disorders App 20110112088 - Bennani; Youssef L. ; et al.	2011-05-12
Indole Derivatives As Histamine 3 Receptor Inhibitors For The Treatment Of Cognitive And Sleep Disorders, Obesity And Other Cns Disorders App 20110059966 - Bennani; Youssef L. ; et al.	2011-03-10
Pyrazoles for the treatment of obesity and other CNS disorders Grant 7,897,634 - Bennani , et al. March 1, 2	2011-03-01
Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disorders Grant 7,855,224 - Bennani , et al. December 21, 2	2010-12-21
Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disorders Grant 7,528,262 - Bennani , et al. May 5, 2	2009-05-05
Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disorders App 20090036446 - Bennani; Youssef L. ; et al.	2009-02-05
Pyrazoles for the treatment of obesity and other CNS disorders App 20070197526 - Bennani; Youssef L. ; et al.	2007-08-23
Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disorders App 20070161676 - Bennani; Youssef L. ; et al.	2007-07-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.